Author

Rubén Fernández‐Rodríguez

Icahn School of Medicine at Mount SinaiORCID 0000-0001-9127-1735Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Mihaela SkobeiD· 2 shared A. Cole Edwards· 1 shared Adolfo García‐SastreiD· 1 shared Alice Oliffson KamphorstiD· 1 shared Amir HorowitziD· 1 shared Anita RogiciD· 1 shared Anthony MendozaiD· 1 shared Ignacio MenaiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Mihaela SkobeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyAntibodiesPeer-reviewedApr 20, 2026

A Human Recombinant Antibody Against DRP1 Serine 616 Phosphorylation Enables Detection of BRAFV600E-Associated Mitochondrial Division in Cancer

Shanon Nizard, Yiyang Chen, Madhavika N. Serasinghe…·Jerry E. Chipuk

This paper develops a human recombinant antibody (3G11) specific for DRP1-S616 phosphorylation, demonstrating its utility in detecting mitochondrial division in cancer, particularly in BRAFV600E-associated diseases.

DOI 10.3390/antib15020038

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 27, 2025

Lymphangiogenesis driven by VEGF-C reshapes tumor immune landscape and enables tumor eradication by viral immunotherapy

Rubén Fernández‐Rodríguez, Sara Cuadrado‐Castano, A. Cole Edwards…·Mihaela Skobe

This study shows that VEGF-C promotes lymphangiogenesis in tumors, enhancing immune cell infiltration and enabling complete tumor eradication with viral immunotherapy.

1 citation

mouseexperimental assay

𝕏 PostBluesky